US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Imugene Ltd (IMUOD) 銘柄情報

Imugene Ltd (IMUOD)

0.001

0.00

( 0.00% )

更新日時： 09:00:00

Imugene Ltd (IMUOD) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.006

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,287,035

発行済株式数

415,835,040

配当利回り

PER

-0.42

1 株当たり利益 (EPS)

-0.23

歳入

3.94M

純利益

-58.5M

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial target... Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA, a combination of genomic sequences from various vaccinia virus strains to generate potent virus in phase 1 clinical trial for mixed advanced solid tumours; and CF33 CD19 chimeric antigen receptor T cells therapies to target solid tumours in phase 1 study. The company also develops CF33 oncolytic virotherapy; HER-VAXX, a B-cell immunotherapy cancer vaccine completed phase 2 clinical trial to target metastatic gastric cancer; HERIZON, which is in Phase 1b/2 study for HER-Vaxx and chemotherapy; PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling in phase 2 clinical trial to target non-small cell lung cancer; and NeoPOLEM in phase 2 study for MSI-high colorectal cancer. Imugene Limited is headquartered in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.imugene.com

本社

Sydney, Australia

設立

-

Imugene Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker IMUOD. The last closing price for Imugene was AUD0. Over the last year, Imugene shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Imugene currently has 415,835,040 shares in issue. The market capitalisation of Imugene is AUD415,835.04 . Imugene has a price to earnings ratio (PE ratio) of -0.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

IMUOD - Frequently Asked Questions (FAQ)

What is the current Imugene Ltd share price?

The current share price of Imugene Ltd is AUD 0.001

How many Imugene Ltd shares are in issue?

Imugene Ltd has 415,835,040 shares in issue

What is the market cap of Imugene Ltd?

The market capitalisation of Imugene Ltd is AUD 415.84k

What is the 1 year trading range for Imugene Ltd share price?

Imugene Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Imugene Ltd?

The price to earnings ratio of Imugene Ltd is -0.42

What is the cash to sales ratio of Imugene Ltd?

The cash to sales ratio of Imugene Ltd is 10.02

What is the registered address of Imugene Ltd?

The registered address for Imugene Ltd is 4-6 Bligh Street, Sydney, New South Wales, 2000

What is the Imugene Ltd website address?

The website address for Imugene Ltd is www.imugene.com

Which industry sector does Imugene Ltd operate in?

Imugene Ltd operates in the Biotechnology & Life Sciences sector

Just give me $1.50

Just give me $1.50 4分前

Does this mean every penny spent on this case was a complete waste of time since we can't launch until the patents are up?

Or in other words, we got absolutely nothing out of it?

Thanks.

along4zride

along4zride 4分前

BIG IPO TOMORROW. Real company on major exchange. Excitement enthusiasm, whole world watching. Will be setting a benchmark for all going forward. Not some pink sheet (FNMA) wanna be has been in conservatorship with total profit sweep waiting for a hand out . Most can recognize the difference. I am

nowwhat2

nowwhat2 4分前

The 200 = Wow
https://schrts.co/CWanBemw

https://investorshub.advfn.com/uimage/uploads/2026/6/12/pynusbag_june_11_sweet_but_vol.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dwwgnbag_june_11_snip_vol_nuts.jpg

https://i

Oleblue

Oleblue 7分前

Chad Williams, CEO of Honey Badger Silver Inc. | Rule Symposium 2026: Rick Rule interviews

https://youtu.be/zGol2-Jz7p8

Got Germanium and Tungsten?

Daily Chart
https://schrts.co/kbyFeMMu

JimBoStevens

JimBoStevens 10分前

That Weekly W% up and Sto down, while pinching OMFG spells KaBoom to me

Overall Market will be crazy tomorrow perfect timing... well see just dont see a better time then now

Just give me $1.50

Just give me $1.50 10分前

We have INDEED met the requirement of at least 10 likes.

Therefore, AS PROMISED, here are the documents (11 pages):

STIPULATION of Dismissal and Proposed Order Regarding Irrevocable Covenant Not to Come to Market by ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC.

jour_trader

jour_trader 12分前

That’s great insight. Thanks for sharing. At least 14 months away from launch and going into final stages of FDA decision. Wonder where Accord is in the process.

SSKILLZ1

SSKILLZ1 14分前

OPFI

The thing I really love about OPFI is this acquisition I believe this will be a game changer to profitability with a combo of product and geographic diversification, combined with a lower cost of funds. I simply think this acquisition going forward will be a strong tailwind to th

MonkRebel181

MonkRebel181 16分前

What’s another 20 years to see .50 again.

Dead money lies here. Invest in VOO and you’ll come out much farther ahead. This is a terrible investment that will not pay off for a century at this point.

Voo and chill people. Why park money in a dead stock that won’t see a 2

mrwrn2010

mrwrn2010 16分前

Now let’s see if the Lowenstein clown shows back up on this board anytime soon. Then there will be no doubt whatsoever that they were involved in this case. Lmao.

PRmaniac

PRmaniac 21分前

Yesterday’s FINRA short volume ratio came in at 45.35% on ~40M total volume. Almost half of the shares traded yesterday were short sales even with reg sho in effect.

Could go lower. We'll see.
Will we get a Friday slam? Market has not yet digested what I believe to be good new

BigB111

BigB111 23分前

I wonder who dumped the million shares today and who picked them up? 🤔 $TMMI

SSKILLZ1

SSKILLZ1 23分前

INTU

I don't know where your coming up with these numbers but they are just not right in my opinion.

The adjusted tax rate through 9 months ended was 24% roughly for both years.

Pretax income for FY 26 non gaap is roughly 14.4% for nine months ended so f

4retire

4retire 23分前

Once again a personal attack. You are predictable. Yes I said that if their CFO is given the power to control spending and capital projects then KULR could become viable. They have lacked discipline for years. They can’t continue burning through millions of dollars with minimal results..

mrwrn2010

mrwrn2010 23分前

Just bought the stipulation document off Pacer, cost me slightly over 3 ELTP shares at current price. Lol. Looks like they both agreed to drop the case and as part of that, Elite agreed to not market OxyContin until the patents in this case expire, which this document says “the Asserted Patents all

zzNine2Five

zzNine2Five 24分前

I used to think Goldman Sachs would be the pick, now I am suspect ing CITI as Goldman Sachs have their hands all over on a couple of mega AI IPOs.

jjjjjjjj

jjjjjjjj 26分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

IT IS DAMN IF IT GOES UP, DAMN IF IT GOES DOWN!which is it??? Let it flow freely . The harder the push, the harder the pullback. ROME WAS NOT BUILT IN ONE DAY. S

zerosnoop

zerosnoop 27分前

How high will the share price go after India or Malaysia sign off on a CONTRACT ? Wow INDIA want 150 PROVEN AOT units X $5,000,000 each = $750,000,000 CONTRACT for QS Energy. The FACTS are in the latest 10K filing

The Company's commercialization efforts in India, initiated t

Smile AOT Works

Smile AOT Works 32分前

As a result, the Company views AOT 3.0 as commercially ready: not only does it reduce viscosity and improve flow, it does so at a scale and reliability that can translate into meaningful revenue uplift, cost efficiency, and sustainability benefits for pipeline operators and crude owners. That is the

Smile AOT Works

Smile AOT Works 34分前

The AOT reduces pressure drop, increases flow volume, and minimizes power consumption.

AOT’s success lies in its ability to optimize crude oil transportation, making it more efficient and environmentally friendly.

MODULAR SCALABLE VERSATILE
FROM SINGLE TO MULTIPL

Helter Skelter

Helter Skelter 35分前

Good day. Good night.

https://investorshub.advfn.com/uimage/uploads/2026/6/11/vffktBB_iHub_stats_chart_UP_day_061126.png

$BB

Helter Skelter

Helter Skelter 38分前

Qualcomm and BlackBerry (BB) operate at fundamentally different layers of the Software-Defined Vehicle (SDV) stack in China, rendering them closer to highly integrated partners than zero-sum competitors. While Qualcomm dominates the high-performance hardware and silicon-layer ecosystem, Blac

mike_usa

mike_usa 38分前

zzNine2Five , Agree with you. Also have a question about underwriting. Who's doing that and that may be the final process before IPO ?

1kgwxman

1kgwxman 39分前

I seriously doubt Nelson or Hawkins care who checks their grammar. 😆
Pathetic attempts to scare shareholders and attack AMFN with meaningless accusations are not working.

SSKILLZ1

SSKILLZ1 40分前

Software stocks like PGY, VYX and CCSI were up nicely and they're not cybersecurity

No offense but those stock probably don't get sold in a algo today, with big market cap companies in software they got hit hard. ADBE, WDAY, INTU, CRM, HUBS, TEAM, Etc. The smaller companies probably

Atcl Barr Nts Lkd S&p500...

Champion Gaming

Constellation Acquisitio... (PK)

Nucoal Resources NL

Invesco Nasdaq Free Cash...

Macquarie Gp 31

Amundi FTSE MIB Daily 2x...

Banc of California

Credit Suisse NASDAQ OMX...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。